On August 15th, the National Health and Family Planning Commission held a media communication meeting on the progress of medical quality and service accessibility in recent years. The conference revealed that in May this year, the internationally renowned journal "The Lancet" published a ranking of medical quality and accessibility involving 195 countries and regions. From 1990 to 2015, China's ranking progress ranked third globally.

      Guo Yanhong, Deputy Director of the Medical Administration of the National Health and Family Planning Commission, introduced that research shows that from 1990 to 2015, China was one of the countries with the greatest progress in medical quality. The HAQ (Medical Quality and Accessibility) index increased from 49.5 to 74.2 (global average 53.7, compared to 81.3 in the United States), ranking from 110th to 60th, ranking third in the world in terms of progress. At the same time, the gap in medical service quality between regions in China has narrowed from 6.7 in 1990 to 1.2 in 2015 (the global gap in medical service quality between regions in 2015 was 20.1).

    Guo Yanhong said that for a long time, China's total medical service volume has ranked first in the world and continues to rise. The task of managing medical service quality is arduous. After years of exploration, China has gradually formed a new pattern of diversified co governance with government supervision, institutional autonomy, industry self-discipline, and social supervision. The improvement of medical quality in China is accompanied by the rapid development of medical technology, with modern medical technology characterized by individualization and minimally invasive techniques widely used in clinical practice. In terms of individualization, the diagnosis and treatment of diseases are no longer limited to the level of etiology and pathology, but have taken a big step towards the level of patients and pathogen genes. At the same time, the patient-centered multidisciplinary diagnosis and treatment model (MDT) is continuously advancing, providing patients with more comprehensive, reasonable, and scientific diagnosis and treatment plans.

It is reported that in recent years, the level of medical quality and safety in China has steadily improved. The hospitalization mortality rate gradually decreases and stabilizes at a relatively low level. In 2015, the total mortality rates of inpatients in tertiary public general hospitals and secondary public general hospitals were 0.71% and 0.48%, respectively, a decrease of 0.03 percentage points and 0.06 percentage points compared to 2014; The hospitalization mortality rates of surgical patients were 0.38% and 0.21%, respectively, with a decrease of 0.03 percentage points in tertiary comprehensive hospitals compared to 2014, and the same in secondary comprehensive hospitals compared to 2014. The efficiency of medical services is constantly improving, and the medical service capacity is significantly enhanced. The usage rate of antibacterial drugs in medical institutions has decreased by about 50%, and the upward trend of bacterial resistance in medical institutions has been curbed. In terms of accessibility to medical services, according to incomplete statistics, the average medical treatment rate within counties in China has reached 82.7%, an increase of 2.3 percentage points compared to the end of 2016. About 50% of county hospitals are able to carry out complicated operations such as craniocerebral tumor surgery and cervical vertebra surgery. The diagnostic coincidence rate of patients admitted and discharged from county hospitals, the diagnostic coincidence rate before and after surgery, and the pathological and clinical diagnostic coincidence rate all exceed 92%. In the first half of this year, the proportion of diagnosis and treatment in grassroots medical and health institutions increased by an average of 4.7%, and the number of patients transferred from higher-level medical institutions to lower level medical institutions increased by 15.1% year-on-year.